Rights and permissions
About this article
Cite this article
Cisplatin and Doxorubicin as Second-Line Therapy in Ovarian Cancer. Inpharma Wkly. 447, 9 (1984). https://doi.org/10.1007/BF03315737
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03315737